STOCK TITAN

MDWERKS INC Form 4 Filings

MDWK OTC

Every Form 4 that MDWERKS INC (MDWK) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow MDWK and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MDWK filings page.

Rhea-AI Summary

MDWerks, Inc. (symbol: MDWK) is the issuer of record for a Form 4 filing submitted to the SEC.

Rhea-AI Summary

MDWerks, Inc. (symbol: MDWK) is the issuer of record for a Form 4 filing submitted to the SEC.

Rhea-AI Summary

MDWerks, Inc. (symbol: MDWK) is the issuer of record for a Form 4 filing submitted to the SEC.

Rhea-AI Summary

MDWerks, Inc. (MDWK) reported that director Roy Monroe Milner acquired 150,804 shares of common stock on a grant/award basis at a reported value of $0.07 per share. The award was made quarterly under his February 11, 2026 Employment Agreement and the MDWerks, Inc. 2025 Equity Incentive Plan, approved by the board under Rule 16b-3. Following this grant, he holds 297,350 common shares directly.

Rhea-AI Summary

Milner Roy Monroe reported acquisition or exercise transactions in this Form 4 filing.

MDWerks, Inc. director Milner Roy Monroe reported two stock awards of common shares received as compensation under his employment agreement and the MDWerks, Inc. 2025 Equity Incentive Plan. He was granted 100,000 shares on February 11, 2026 at $0.15 per share and 46,546 shares on May 15, 2026 at $0.13 per share, both approved by the board and issued in accordance with Rule 16b-3. After these awards, he holds 146,546 common shares directly. The company notes that the Form 4 for the February 11, 2026 grant was inadvertently not filed at the time of that earlier issuance.

Rhea-AI Summary

Blackstone Richard reported acquisition or exercise transactions in this Form 4 filing.

MDWerks, Inc. director Richard Blackstone received a grant of 46,546 shares of common stock at $0.13 per share. These shares were issued on a quarterly basis under his Employment Agreement and the MDWerks, Inc. 2025 Equity Incentive Plan, with board approval under Rule 16b-3. Following this compensation award, he directly holds 956,132 common shares.

Rhea-AI Summary

Brocopp Timothy reported acquisition or exercise transactions in this Form 4 filing.

MDWerks, Inc. director Timothy Brocopp received a grant of 46,546 shares of common stock on May 15, 2026 at a price of $0.13 per share. This award was issued quarterly under his November 18, 2024 Employment Agreement and the MDWerks, Inc. 2025 Equity Incentive Plan, with board approval under Rule 16b-3. Following this compensation grant, he holds 3,122,798 common shares directly.

Rhea-AI Summary

MDWerks, Inc. director Timothy Brocopp reported an acquisition of common stock through an equity grant. He received 85,575 shares of common stock at a stated value of $0.15 per share on a grant/award basis, not an open-market purchase. Following this grant, his direct holdings increased to 3,076,252 common shares.

The shares were issued on a quarterly basis under his Employment Agreement dated November 18, 2024 and granted pursuant to the MDWerks, Inc. 2025 Equity Incentive Plan. The board of directors approved the grant, which was made in accordance with Rule 16b-3 under the Securities Exchange Act of 1934.

Rhea-AI Summary

Blackstone Richard reported acquisition or exercise transactions in this Form 4 filing.

MDWerks, Inc. director Richard Blackstone received a grant of 85,575 shares of common stock on February 23, 2026 at a stated price of $0.15 per share. The award was issued quarterly under his Employment Agreement and the MDWerks, Inc. 2025 Equity Incentive Plan, as approved by the board under Rule 16b-3. Following this grant, his directly held common stock totaled 909,586 shares.

Rhea-AI Summary

MDWerks, Inc. director and reporting person Timothy Brocopp reported a new grant of company common stock. On 11/13/2025, he acquired 65,325 shares of MDWerks common stock at a stated price of $0.153 per share. After this transaction, he beneficially owned 2,990,677 shares of MDWerks common stock in direct ownership.

The filing explains that this grant was issued on a quarterly basis under an Employment Agreement between the reporting person and MDWerks dated November 18, 2024. The grant was approved by MDWerks’ board of directors and was made in accordance with Rule 16b-3 under the Securities Exchange Act of 1934, which governs certain insider equity awards.

Rhea-AI Summary

MDWerks, Inc. director Richard Blackstone reported a quarterly equity compensation grant. On 11/13/2025, he acquired 65,325 shares of MDWerks common stock at a stated price of $0.153 per share, classified as an acquisition under his existing arrangements with the company. Following this grant, he beneficially owned 824,011 shares of MDWerks common stock in direct ownership.

The filing explains that these shares were issued on a quarterly basis under an Employment Agreement between Blackstone and MDWerks dated December 3, 2024. The grant was approved by the company’s board of directors and made in accordance with Rule 16b-3 under the Securities Exchange Act of 1934, which governs certain insider compensation-related transactions.